A Study of RTA 402 in Chronic Kidney Disease (CKD) Patients With Type 2 Diabetes Mellitus

A Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-393(2) in Healthy Volunteers Under Fed Conditions

NCT05347576 ·Status: COMPLETED ·Phase: PHASE1

Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-393 in Healthy Subjects

NCT04260438 ·Status: COMPLETED ·Phase: PHASE1

Clinical Trial to Evaluate the Drug Drug Interaction of CKD-501 and D308

NCT03616392 ·Status: COMPLETED ·Phase: PHASE1

A Clinical Trial to Evaluate the Pharmacokinetic Profiles and Safety of CKD-383.

NCT04810676 ·Status: COMPLETED ·Phase: PHASE1

Effect of Dorzagliatin on Renal Function Outcomes in People With Type 2 Diabetes: a Multicentric, Prospective, Randomized Study.

NCT06222476 ·Status: NOT_YET_RECRUITING ·Phase: NA

Clinical Study to Evaluate the Pharmacokinetics and Safety of CKD-383 0.25/12.5/1000mg in Healthy Volunteers

NCT07304726 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetics, Safety and Tolerability of CKD-387 10/500mg BE Phase1

NCT04156685 ·Status: COMPLETED ·Phase: PHASE1

Evaluate the Glycemic Control of CKD-501 in Type 2 Diabetes Mellitus

NCT01030679 ·Status: COMPLETED ·Phase: PHASE2

Phase IIa Trial to Determine the Effects of Bardoxolone Methyl on Renal Function in Patients With Diabetic Nephropathy

NCT00664027 ·Status: COMPLETED ·Phase: PHASE2

A Multicenter, Open Label, Single Dose Study to Evaluate the Effect of Renal Insufficiency on the Pharmacokinetics of SK 0403

NCT01131091 ·Status: COMPLETED ·Phase: PHASE1

Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-389

NCT04322032 ·Status: UNKNOWN ·Phase: PHASE1

Phase II Pharmacodynamic Trial to Determine the Effects of Bardoxolone Methyl on eGFR in Patients With Type 2 Diabetes and Chronic Kidney Disease

NCT01053936 ·Status: COMPLETED ·Phase: PHASE2

Evaluate the Pharmacokinetics and Safety Between the Treatment of CKD-383 and Treatment of CKD-501, D745, D150, and D029

NCT05897216 ·Status: COMPLETED ·Phase: PHASE1

Safety and Pharmacokinetics/Pharmacodynamics of SHR3824 in Type 2 Diabetes Patients With Renal Insufficient

NCT03159832 ·Status: UNKNOWN ·Phase: PHASE1

Trial to Determine the Effects of Bardoxolone Methyl on eGFR in Patients With Type 2 Diabetes and Chronic Kidney Disease

NCT00811889 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of HRS-7535 Tablets in Adults With Diabetic Kidney Disease in Type 2 Diabetes

NCT06415214 ·Status: COMPLETED ·Phase: PHASE2

The Clinical Trial to Investigate the Pharmacokinetics and Safety/Tolerability of CKD-375

NCT03848637 ·Status: UNKNOWN ·Phase: PHASE1

Clinical Study to Evaluate the Pharmacokinetics and Safety of CKD-383 0.5/10/1000mg in Healthy Volunteers

NCT07304700 ·Status: COMPLETED ·Phase: PHASE1

An Extended Treatment Study of MT-3995 in Patients With Diabetic Nephropathy

NCT02676401 ·Status: COMPLETED ·Phase: PHASE2

Specified Drug-Use Survey of Trelagliptin Tablets "Survey on Long-term Use in Type 2 Diabetes Mellitus Patients With Severe Renal Impairment or End-stage Renal Disease"

NCT04285983 ·Status: COMPLETED

The Clinical Trial to Investigate the Pharmacokinetics and Safety/Tolerability of CKD-387 Under Fed Condition

NCT03738449 ·Status: COMPLETED ·Phase: PHASE1

Clinical Trial to Investigate the Pharmacokinetics and Safety of CKD-393

NCT04706286 ·Status: UNKNOWN ·Phase: PHASE1

Clinical Study to Evaluate the Pharmacokinetics and Safety of CKD-383 0.5/25/1000mg in Healthy Volunteers

NCT07304687 ·Status: COMPLETED ·Phase: PHASE1

A Clinical Trial to Investigate the Pharmacokinetics and Safety/Tolerability of CKD-386 in Healthy Adult Volunteers

NCT04223895 ·Status: UNKNOWN ·Phase: PHASE1

Therapeutic Drug Use for CKD Patients

NCT05818995 ·Status: UNKNOWN